BLUEPRINT MEDICINES CORPORATION Earnings Per Share (Diluted)
BLUEPRINT MEDICINES CORPORATION reported Earnings Per Share (Diluted) of $0.01 per share for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-05-01
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for the quarter ending 2025-03-31 was $0.01, a 99.29% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for the quarter ending 2024-09-30 was -$0.89.
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for the quarter ending 2024-06-30 was -$0.80.
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for the quarter ending 2024-03-31 was $1.40.
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for fiscal 2024 was -$1.07.
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for fiscal 2023 was -$8.37.
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for fiscal 2022 was -$9.35.
- BLUEPRINT MEDICINES CORPORATION earnings per share, diluted for fiscal 2021 was -$11.01, a 296.96% decline from fiscal 2020.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.01 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | -$1.07 10-K · filed 2025-02-13 | |||
| 2024-09-30 | -$0.89 10-Q · filed 2024-10-30 | -$0.27 10-Q · filed 2024-10-30 | ||
| 2024-06-30 | -$0.80 10-Q · filed 2024-08-01 | $0.61 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | $1.40 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | -$8.37 10-K · filed 2025-02-13 | |||
| 2023-09-30 | -$2.20 10-Q · filed 2024-10-30 | -$6.55 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | -$2.19 10-Q · filed 2024-08-01 | -$4.35 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | -$2.15 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$9.35 10-K · filed 2025-02-13 | |||
| 2022-09-30 | -$2.23 10-Q · filed 2023-10-26 | -$6.70 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | -$2.68 10-Q · filed 2023-08-02 | -$4.47 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | -$1.79 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$5.40 derived: net income ÷ weighted average shares · filed 2024-02-15 | -$7.41 derived: net income ÷ weighted average shares · filed 2024-02-15 | -$11.01 10-K · filed 2024-02-15 | |
| 2021-09-30 | -$2.00 10-Q · filed 2022-11-01 | -$5.58 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | -$1.86 10-Q · filed 2022-08-02 | -$3.58 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | -$1.72 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-02-16 | $9.54 derived: net income ÷ weighted average shares · filed 2023-02-16 | $5.59 10-K · filed 2023-02-16 | |
| 2020-09-30 | $11.16 10-Q · filed 2021-10-28 | $7.20 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | -$2.28 10-Q · filed 2021-07-29 | -$4.39 10-Q · filed 2021-07-29 | ||
| 2019-12-31 | -$1.35 derived: net income ÷ weighted average shares · filed 2022-02-17 | -$3.27 derived: net income ÷ weighted average shares · filed 2022-02-17 | -$7.27 10-K · filed 2022-02-17 | |
| 2019-09-30 | -$1.93 10-Q · filed 2020-10-29 | -$5.94 10-Q · filed 2020-10-29 | ||
| 2018-12-31 | -$5.39 10-K · filed 2021-02-17 |